Bevacizumab-induced hypertension: pathogenesis and management.

Syrigos, Kostas N; Karapanagiotou, Eleni; Boura, Paraskevi; Manegold, Christian; Harrington, Kevin

Syrigos, Kostas N; Karapanagiotou, Eleni; Boura, Paraskevi; Manegold, Christian; Harrington, Kevin.

Affiliation

Syrigos KN; Oncology Unit, Third Department of Medicine, Sotiria General Hospital, Athens Medical School, Greece.

BioDrugs ; 25(3): 159-69, 2011 Jun 01.

Article in En | MEDLINE | ID: mdl-21627340

Subject(s)

Angiogenesis Inhibitors/adverse effects; Antibodies, Monoclonal/adverse effects; Hypertension/chemically induced; Neoplasms/drug therapy; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Breast Neoplasms/drug therapy; Carcinoma, Non-Small-Cell Lung/drug therapy; Colorectal Neoplasms/drug therapy; Glioblastoma/drug therapy; Humans; Hypertension/drug therapy; Kidney Neoplasms/drug therapy; Lung Neoplasms/drug therapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angiogenesis Inhibitors / Vascular Endothelial Growth Factor A / Hypertension / Antibodies, Monoclonal / Neoplasms Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: BioDrugs Journal subject: ALERGIA E IMUNOLOGIA / GENETICA MEDICA / TERAPEUTICA / TERAPIA POR MEDICAMENTOS Year: 2011 Document type: Article Affiliation country: Greece Country of publication: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google